US EditionAfter some Success in Space, Varda Raises $187 Million to Expand Ambitions
UNITED STATES, JUL 10 – Varda Space Industries secured $187 million to enhance robotic drug manufacturing, enabling drug formulations impossible on Earth due to microgravity effects, with three launches completed so far.
- On July 10, 2025, Varda Space Industries announced it secured $187 million in its Series C financing round at its headquarters in El Segundo, California.
- The funding comes as Varda builds on its successful 2023 launch of the W-1 capsule and completion of three drug manufacturing missions in low Earth orbit.
- Varda has expanded terrestrially with new offices in Huntsville, Alaska, and a lab in El Segundo to support complex drug crystallization in microgravity.
- Adrian Radocea, the chief science officer, stated that expanding the laboratory facilities reflects the company's confidence that producing pharmaceuticals in space will be key to developing the orbital economy.
- Varda plans to increase flight cadence and develop a microgravity-enabled pharmaceutical lab to unlock manufacturing of drugs that are difficult to make on Earth.
18 Articles
18 Articles
Varda Space Industries raises $187 million
Varda Space Industries, a company developing spacecraft for microgravity life sciences and hypersonics research, has raised $187 million to expand the scope and cadence of its missions. The post Varda Space Industries raises $187 million appeared first on SpaceNews.
Trump Taps Duffy for NASA Role Amid Space Industry Developments
Trump Taps Duffy for NASA Role Amid Space Industry Developments In a decisive move, U.S. President Donald Trump has appointed Transportation Secretary Sean Duffy as the interim head of NASA. Duffy steps into a role that takes center stage amid Trump's unresolved tension with Elon Musk, who had backed Jared Isaacman for the position.Illustrating another leap in the space industry, Varda Space Industries has successfully raised $187 million in a v…
Channel News Asia
Varda Space raises $187 million to accelerate development of drugs in space
Varda Space Industries said on Thursday it has raised $187 million in a funding round led by venture capital firms Natural Capital and Shrug Capital, to boost the technology for robotic drug manufacturing in space. The latest round, which included participation from Lux Capital, billionaire Peter Thiel, Found
Coverage Details
Bias Distribution
- 82% of the sources are Center
To view factuality data please Upgrade to Premium
